This federal contract award, identified as SPE2DB22D1202|SPE2DB25FUKX0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,589.45 firm fixed-price delivery order is for the procurement of 4,566,555,949 units of the medication Ondansetron ODT 4 mg Tablet, with a completion date of November 27, 2024.
The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order appears to be a task order placed against that larger IDC contract.
Generated 2/25/25, 9:50 AM